Biomind Labs announces positive results of Phase 2 clinical trial of BMND08 for depression & anxiety in Alzheimer’s disease
Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg
Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg
This newly set up Centre for bio-analytical testing has already received European Regulatory Authority clearance recently
Cipla completes transfer of Generics Business Undertaking
The plant will drive pharmaceutical innovation in the Northeastern India
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
Survodutide has potential to become best-in-class treatment for metabolic dysfunction-associated steatohepatitis
The said Unit complies with the prescribed Good Manufacturing practices as per relevant WHO technical Report Series
The board gave in-principle approval for expansion of company's footprint in Lucknow
Leishmaniasis is caused by protozoan parasites which are transmitted by the bite of infected female phlebotomine sandflies
Experts discussed the latest innovations, challenges, & collaborative solutions in the fight against TB at NHWIC-2024 held at AIIMS, Delhi
Subscribe To Our Newsletter & Stay Updated